Solving Challenging Cases in Dermatology: This Is How I Do It
Valerie D. Callender, MD, the Founder and Medical Director of the Callender Dermatology & Cosmetic Center and Founder and Principal Investigator for Callender Center for Clinical Research in Washington DC, shares her approaches to challenging cases of acne, deep-etched lines, and melasma.
Embracing Combination Therapy in Rosacea
Identify and document every feature of rosacea and treat each accordingly using a combination of therapies. “Don’t try to do a one-hit wonder,” says Birmingham, Ala-based dermatologist Julie C. Harper, MD, the Past President of the American Acne and Rosacea Society.
Achieving Deep Itch Relief With JAK Inhibitors
The speed and depth of itch relief that is possible today with topical and systemic Janus kinase (JAK) inhibitors is “literally unbelievable,” says Matthew Zirwas, MD, a dermatologist in Bexley, Ohio.
Pediatric Acne Update
Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children’s Hospital-San Diego and Professor of Dermatology and Pediatrics and Vice-chair of the Department of Dermatology at UC San Diego School of Medicine, discusses recent advances in treating pediatric acne including the use of Cabtreo (clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide, Ortho Dermatologics) and spironolactone […]
A Sneak Peek in the Toxin Pipeline
Novel neuromodulator products including ready-to-go liquid formulations and new indications for existing toxins promise to further invigorate the aesthetic landscape in 2024 and beyond. Joel L. Cohen, MD, Director of About Skin Dermatology and DermSurgery in Greenwood Village and Lone Tree, CO, updates viewers on what may be coming down the pike.
Heart of the Matter: Understanding CV Risk in Psoriasis
Joel M Gelfand, MD, MSCE, the James J. Leyden Professor of Dermatology & Epidemiology, Director of the Center for Clinical Sciences in Dermatology, Director Psoriasis & Phototherapy Treatment Center at the University of Pennsylvania Perelman School of Medicine in Philadelphia, highlights recent research on cardiovascular risk in psoriasis and stresses the importance of multidisciplinary care […]
Managing Patient Expectations in Vitiligo
Treating vitiligo is a marathon, not a sprint, and it’s important that patients understand this when starting therapy, explains John E. Harris, MD, PhD, the founding Director of the Vitiligo Clinic and Research Center, founding director of the Autoimmune Therapeutics Institute and Professor and Chair in the Department of Dermatology at UMass Chan Medical School in […]
Deucravacitinib Shows Efficacy Signal in Cutaneous Lupus Erythematosus
Deucravacitinib (Sotyktu, Bristol-Myers Squibb) may help improve cutaneous manifestations in patients with systemic lupus erythematosus, according to a late-breaking study presented at MauiDerm 2024. Deucravacitinib is a first-in-class, oral, selective, allosteric tyrosine kinase 2 inhibitor approved in multiple countries for the treatment of adults with moderate to severe plaque psoriasis. In the 48-week, double-blind, phase […]
Extinguishing Physician Burnout
Rates of physician burnout are at an all-time high due to burdensome prior authorization practices, Medicare payment cuts, and other factors. In this year’s Alan Shalita Memorial Lecture, Jack Resneck, MD, Immediate Past President of the American Medical Association and a dermatologist in San Francisco, discussed how to turn things around..
Optimizing Treatment for Hyperpigmentation
Pearl Grimes, MD, Medical Director of The Vitiligo & Pigmentation Institute of Southern California and a Clinical Professor of Dermatology at the University of California, Los Angeles, discusses advances in understanding the pathogenesis of melasma and post-inflammatory hyperpigmentation and shares how she integrates new non-hydroxychloroquine products into her treatment regimens for hyperpigmentation.